Happy Holidays: ‘Most Favored Nation’ Rule Effective Date Likely To Be Delayed

biopharma congress panel
Health care policy experts Stacey Hughes, executive VP-designate of America's Health Insurance Plans, Foley Hoag partner Ross Margulies and BGR's Remy Brim discuss the fate of President Trump’s eleventh-hour drug pricing rules during the Biopharma Congress. • Source: screenshot

More from Pricing Debate

More from Market Access